Numerous studies have addressed the regulatory mechanisms and roles of PRMT1 in human cancers including breast, prostate, lung cancer, and leukemia, but little is known about the regulatory roles of PRMT1 in CRC progression [8]. This evidence concerns the gene PRMT1 and lung cancer.